Read the latest blogs from across our work within the secondary breast cancer community. From blogs on fundraising, research findings, information sharing, corporate achievements, community support and stories, celebrate with us as we work together to Make 2nds Count.

Carboplatin - Patient Experience
As part of our series looking at different chemotherapy treatments for secondary breast cancer, Sarah Michaeloudis shares her experience of Carboplatin this week.

Types of Chemotherapy for Secondary Breast Cancer: Carboplatin
We are looking at different types of chemotherapy - how you take it and possible side-effects - and then hearing from a patient about their experience. This week it’s Carboplatin.

Eribulin Mesylate - Patient Experience
As part of our series looking at different chemotherapy treatments for secondary breast cancer, Emma Emery shares her experience of Eribulin Mesylate this week.

Types of Chemotherapy for Secondary Breast Cancer: Eribulin Mesylate
Next in our series covering different types of chemotherapy is Eribulin Mesylate. What is Eribulin Mesylate?

What do the different stages of breast cancer mean?
The stage of a cancer tells you how big it is and how far it has spread and helps your team decide which treatment is needed. Stage 1 The earliest stage where the cancer is found in the breast or lymphs nodes under the arm.

Types of Chemotherapy for Secondary Breast Cancer: Gemcitabine
We are looking at different types of chemotherapy - how you take it and possible side-effects - and then hearing from a patient about their experience. This week it’s Gemcitabine.
If you’ve had this chemotherapy as part of your treatment and you’d be happy to share your experience with us, please email support@make2ndscount.co.uk and we’ll be in touch.

Epirubicin - Patient Experience
As part of our series looking at different chemotherapy treatments for secondary breast cancer, Val Boxall shares her experience of Epirubicin) this week.

Types of Chemotherapy for Secondary Breast Cancer: Epirubicin
We are looking at different types of chemotherapy - how you take it and possible side-effects - and then hearing from a patient about their experience. This week it’s Epirubicin.

Update from University of Edinburgh’s Breast Cancer Transitional Research Group
We talked to Fiona Semple, Senior Post Doctoral Fellow, to find out more about the pioneering research project Make 2nds Count is funding with the Edinburgh Cancer Research Centre. Tell us about your role at the University of Edinburgh’s Breast Cancer Translational Research Group?

Nab Paclitaxel - Patient Experience
As part of our series looking at different chemotherapy treatments for secondary breast cancer, Terri Read shares her experience of Nab Paclitaxel (Abraxane) this week. When were you diagnosed with secondary breast cancer?

Supporting and Empowering Secondary Breast Cancer Patients Q & A with Make 2nds Count
Thank you to Erin & the MyTomorrow's team for taking the time to talk to Claire about our work with secondary breast cancer patients.
Find out more about the work of MyTomorrows here

SECONDARY BREAST CANCER AWARENESS SHOULD BE A 365 DAY-A-YEAR CAMPAIGN
SECONDARY BREAST CANCER AWARENESS SHOULD BE A 365 DAY-A-YEAR CAMPAIGN Vital education needed for the forgotten cancer marked on 13th October each year Woeful ignorance of secondary breast cancer requires more than just a single awareness day today (October 13) to educate the public about this forgotten form of the disease. Charity Make 2nds Count which is leading a campaign to highlight secondary breast cancer, a disease currently killing 1000 women a month in the UK, says it needs to be a year-round initiative to prevent lives being destroyed.

Types of Chemotherapy for Secondary Breast Cancer: Nab Paclitaxel
We are looking at different types of chemotherapy - how you take it and possible side-effects - and then hearing from a patient about their experience. This week it’s Nab Paclitaxel.

World Mental Health Day
I had my secondary diagnosis confirmed in 2016 straight after my primary treatment ended so I went from one massive hurdle straight into another one. No real time to breathe and ‘enjoy the moment’.

IGNORANCE OF SECONDARY BREAST CANCER – A DEADLY LACK OF KNOWLEDGE
Two-fifths of UK population are unaware of the condition killing 1,000 women and men every month Astonishingly, just under two-fifths of the adult population in the UK are ignorant about secondary breast cancer, a new survey shows. The disease killed former Girls Aloud singer Sarah Harding last month (Sept) yet according to a YouGov poll just three weeks later, 38% of those questioned say they don’t know what secondary breast cancer is.